HIGHLIGHTS
- who: Friedreich`s Ataxia (FA and collaborators from the Department of Molecular Biosciences, School of Veterinary Medicine, UC Davis, Davis, CA, United States, Department of Life University London, Uxbridge, United Kingdom have published the research: A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models, in the Journal: (JOURNAL)
- what: The studies show that DMF and Resv are useful candidates to potentially alleviate the pathophysiology of FA and that in_vivo studies are crucial to assess the potential benefit of novel drugs.
- how: For vehicletreated cells the authors used the highest . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.